Get access to our best features
Get access to our best features
Published

Uvax Bio Appoints Kevin O’Neill as Interim Chief Executive Officer

Summary by Globe Newswire
NEWARK, Del., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Uvax Bio, LLC, (“Uvax” or “the Company”) a privately held, clinical-stage vaccine company utilizing...
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)